Founded in 2007 on the leading stem cell and developmental biology research, Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics. The company has brought together the foremost scientists from the nationâ€™s research hotbeds (Boston, San Francisco, San Diego and Seattle) who have demonstrated the potential to create and modulate stem cells to restore health.
The backstory is that while others were working towards therapies based on transplanting stem cell-derived cells into patients, Randall Moon (HHMI and University of Washington) and Alex Rives (Arch Venture Capitol) envisioned a different approach to develop regenerative therapies. The concept, based on data from hematopoietic progenitor cells, was that one could modulate the properties of stem cells in vivo using small molecules or biologics. They presented this idea to Arch Venture Capitol in Seattle,... See More
Current Team (15)Update
Funding Rounds (5) - $78.20MUpdate
OVP Venture Partners is a venture capital firm specializing in early-stage technology-based..
Sanofi-Genzyme BioVentures (SGBV) is an important component of Sanofi’s broader global strategy to..
Corporate venture capital
ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs,..
Venrock is a venture capital firm investing in technology and healthcare companies.
Polaris Partners is a venture company investing in digital media, life sciences, and enterprise..
10931 North Torrey Pines Road
La Jolla, CA 92037